Therapeutic results of a novel enzyme-targeting radiosensitization treatment, Kochi oxydol-radiation therapy for unresectable carcinomas II, in patients with stage I primary breast cancer

Linac-based stereotactic radiotherapy has little effect on the majority of advanced neoplasms. Therefore, the novel radiosensitizer Kochi oxydol-radiation therapy for unresectable carcinomas (KORTUC) II, which contains hydrogen peroxide and sodium hyaluronate, was developed. The effectiveness of KOR...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoyama, Nobutaka, Ogawa, Yasuhiro, Yasuoka, Miki, Ohgi, Kenta, Iwasa, Hitomi, Miyatake, Kana, Yoshimatsu, Rika, Yamanishi, Tomoaki, Hamada, Norihiko, Tamura, Taiji, Kobayashi, Kana, Murata, Yoriko, Miyamura, Mitsuhiko, Yamagami, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453170/
https://www.ncbi.nlm.nih.gov/pubmed/28599475
http://dx.doi.org/10.3892/ol.2017.6074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453170/
https://www.ncbi.nlm.nih.gov/pubmed/28599475
http://dx.doi.org/10.3892/ol.2017.6074

Ejemplares similares